Carregant...
Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
The introduction of direct oral anticoagulants (DOACs), such as dabigatran, rivaroxaban, apixaban, edoxaban, and betrixaban, provides safe and effective alternative to previous anticoagulant therapies. DOACs directly, selectively, and reversibly inhibit factors IIa or Xa. The coagulation effect foll...
Guardat en:
| Publicat a: | Biomedicines |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8143174/ https://ncbi.nlm.nih.gov/pubmed/33919121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9050445 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|